The final, formatted version of the article will be published soon.
BRIEF RESEARCH REPORT article
Front. Transplant.
Sec. Transplantation Immunology
Volume 4 - 2025 |
doi: 10.3389/frtra.2025.1525003
This article is part of the Research Topic Novel Small Animal Models for the Study of Transplant Immunology View all articles
Discovery of conserved peptide-MHC epitopes for directly alloreactive CD8 + T cells
Provisionally accepted- 1 The University of Sydney, Darlington, Australia
- 2 Monash University, Melbourne, Victoria, Australia
Mass Spectrometry allied with in-vivo generation of activated alloreactive T cell populations and tetramer screening facilitates the identification of endogenous peptides that are directly recognised in complex with allogeneic Major Histocompatibility class I (MHC I) molecules by alloreactive CD8+ T cells. We had previously used this approach for the discovery of immunogenic self-peptides presented by the allomorph H-2Kb (Kb). In this study, we identified 22 highly immunogenic self-peptides presented by H-2Kd (Kd). Peptide abundance across skin, spleen and liver samples (estimated as the product of the spectral intensity obtained for these samples) was the principal factor influencing recognition of peptide-Kd epitopes. Predicted binding affinity (BA score) and overall peptide hydrophobicity were also independently correlated with immunogenicity, while there was no significant correlation between the IEDB immunogenicity score and the proportion of T cells recognising a given epitope. Eight peptide-Kd epitopes were selected for inclusion in a tetramer panel to detect directly alloreactive CD8+ T cells. This panel bound over 30% of activated alloreactive CD8+ T cells after a prime-boost against Kd . Moreover, the panel identified alloreactive CD8+ T cells within the graft infiltrate, spleen and draining lymph node during rejection of a Kd -bearing heart graft. In conclusion, small animal studies have demonstrated the feasibility of high-throughput approaches for the discovery of pMHC epitopes recognised by directly alloreactive T cells. Translating this approach to the human setting is achievable and will yield both critical insights into the fundamental basis of alloreactivity and powerful tools for immune monitoring in transplantation.
Keywords: allorecognition, Peptide-MHC, CD8 T cell, epitope discovery, Heart transplant, acute rejection, tetramer screening
Received: 08 Nov 2024; Accepted: 13 Jan 2025.
Copyright: © 2025 Hill, Son, Paul, Wang, Ratnaseelan, Denkova, Faridi, Braun, Purcell, Mifsud and Sharland. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Alexandra Francesca Sharland, The University of Sydney, Darlington, Australia
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.